First Midwest Bank Trust Division’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $221K | Sell |
9,500
-2,000
| -17% | -$46.5K | 0.03% | 351 |
|
|
2021
Q3 | $191K | Sell |
11,500
-2,877
| -20% | -$47.8K | 0.03% | 357 |
|
|
2021
Q2 | $351K | Sell |
14,377
-52,348
| -78% | -$1.28M | 0.05% | 309 |
|
|
2021
Q1 | $1.72M | Buy |
66,725
+46,555
| +231% | +$1.2M | 0.24% | 105 |
|
|
2020
Q4 | $1.08M | Sell |
20,170
-23,270
| -54% | -$1.24M | 0.16% | 146 |
|
|
2020
Q3 | $1.79M | Buy |
43,440
+22,596
| +108% | +$932K | 0.28% | 92 |
|
|
2020
Q2 | $1.01M | Sell |
20,844
-1,604
| -7% | -$77.8K | 0.16% | 147 |
|
|
2020
Q1 | $948K | Buy |
22,448
+663
| +3% | +$28K | 0.17% | 136 |
|
|
2019
Q4 | $932K | Sell |
21,785
-505
| -2% | -$21.6K | 0.13% | 176 |
|
|
2019
Q3 | $802K | Sell |
22,290
-18,347
| -45% | -$660K | 0.12% | 190 |
|
|
2019
Q2 | $1.09M | Sell |
40,637
-36,171
| -47% | -$967K | 0.15% | 156 |
|
|
2019
Q1 | $2.06M | Sell |
76,808
-88,558
| -54% | -$2.38M | 0.28% | 96 |
|
|
2018
Q4 | $2.67M | Buy |
165,366
+100,354
| +154% | +$1.62M | 0.4% | 62 |
|
|
2018
Q3 | $1.35M | Buy |
+65,012
| New | +$1.35M | 0.18% | 135 |
|
|
2016
Q3 | – | Sell |
-40,344
| Closed | -$1.31M | – | 439 |
|
|
2016
Q2 | $1.31M | Buy |
40,344
+10,124
| +34% | +$329K | 0.16% | 178 |
|
|
2016
Q1 | $845K | Buy |
+30,220
| New | +$845K | 0.11% | 197 |
|